Head-to-head · Value Score
CoreAge Rx vs BeyondMD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, BeyondMD a 66. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBeyondMD
#302 · Grade C · Watch List
Est. first month
From $139/mo (starting dose, compounded)
Save ~90% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 66 — an est. $99/mo first month, with no teaser step-up baked in. BeyondMD isn't out of it: Someone comparing a mid-priced compounded program who wants the pharmacy type named.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | BeyondMD |
|---|---|---|
| Value Score | 93 (A+) | 66 (C) |
| Est. first month | $99/mo | From $139/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~90% |
| Semaglutide | $99/mo | From $139/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | From $209/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
BeyondMD
beyondMD is a telehealth platform selling compounded GLP-1 weight-loss medication prescribed by licensed clinicians and dispensed by US 503A compounding pharmacies, shipped to most states.
Why it's a deal
- Names the pharmacy type — fully licensed US 503A compounders working from FDA-approved and USP-grade ingredients — rather than saying only "licensed pharmacy"
- States outright that it does not source gray-market or unverified product, which is a claim most of its competitors leave unsaid
- Prescription-only and clinician-reviewed, with home delivery handled discreetly
- Both semaglutide and tirzepatide offered on the same account
The fine print
- Coverage is described as "most states", not all 50, and the site never lists which ones — you find out in the intake
- No price is published before the questionnaire, so the program cannot be compared on cost from the outside
- 503A compounders prepare medication per prescription and are overseen by state boards rather than registered with the FDA, which is a different level of oversight from a 503B facility
- Compounded only — no brand-name Wegovy or Zepbound route if you want one later
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to BeyondMD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.